The role of systemic insulin resistance in modifying mTOR signaling in AD was recently probed using two rat models; ('T2DM': intraperitoneal streptozotocin (STZ) on high fat diet and 'AD': hippocampal Aβ injection). Here, MTOR is linked to type 2 diabetes mellitus.